Accendra Health, Inc.
ACH
$1.12
$0.021.82%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.32% | -11.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.32% | -11.45% | |||
| Cost of Revenue | 0.02% | -9.32% | |||
| Gross Profit | -5.26% | -13.99% | |||
| SG&A Expenses | -4.57% | -6.58% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.83% | -7.84% | |||
| Operating Income | -45.98% | -130.85% | |||
| Income Before Tax | -439.38% | -103.81% | |||
| Income Tax Expenses | 114.75% | -764.27% | |||
| Earnings from Continuing Operations | -1,277.09% | 31.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,277.09% | 88.52% | |||
| EBIT | -45.98% | -130.85% | |||
| EBITDA | 1.81% | 9.09% | |||
| EPS Basic | -1,272.81% | 88.48% | |||
| Normalized Basic EPS | -11.62% | -529.40% | |||
| EPS Diluted | -1,272.81% | 88.55% | |||
| Normalized Diluted EPS | -11.62% | -529.40% | |||
| Average Basic Shares Outstanding | 0.34% | -0.35% | |||
| Average Diluted Shares Outstanding | 0.34% | -0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||